ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-36E9787
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sustained Release Ocular Drug Delivery Systems Market Insights Forecast to 2028
BUY CHAPTERS

Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-36E9787
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
pSivida
Allergan plc
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine

Sustained Release Ocular Drug Delivery Systems Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sustained Release Ocular Drug Delivery Systems Market

Sustained Release Ocular Drug Delivery Systems Market

The global market for Sustained Release Ocular Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sustained Release Ocular Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Ocular Drug Delivery Systems.
The Sustained Release Ocular Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sustained Release Ocular Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sustained Release Ocular Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sustained Release Ocular Drug Delivery Systems Market Report

Report Metric Details
Report Name Sustained Release Ocular Drug Delivery Systems Market
CAGR 5%
Segment by Type
  • Liposome
  • Microcapsules/Nanocapsules
  • Microspheres/Nanosptheres
  • Implants
Segment by Application
  • Cataract
  • Glaucoma
  • Corneal Transplantation
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics, GrayBug, Innocore Pharmaceuticals, OHR Pharmaceuticals, PolyActiva, TheraKine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sustained Release Ocular Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sustained Release Ocular Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Sustained Release Ocular Drug Delivery Systems Market report?

Ans: The main players in the Sustained Release Ocular Drug Delivery Systems Market are pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics, GrayBug, Innocore Pharmaceuticals, OHR Pharmaceuticals, PolyActiva, TheraKine

What are the Application segmentation covered in the Sustained Release Ocular Drug Delivery Systems Market report?

Ans: The Applications covered in the Sustained Release Ocular Drug Delivery Systems Market report are Cataract, Glaucoma, Corneal Transplantation, Others

What are the Type segmentation covered in the Sustained Release Ocular Drug Delivery Systems Market report?

Ans: The Types covered in the Sustained Release Ocular Drug Delivery Systems Market report are Liposome, Microcapsules/Nanocapsules, Microspheres/Nanosptheres, Implants

Recommended Reports

Ophthalmology Therapeutics

Drug Delivery Systems

Eye Care Treatments

1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Product Definition
1.2 Sustained Release Ocular Drug Delivery Systems by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Sustained Release Ocular Drug Delivery Systems by Application
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Value by Application (2024 VS 2031)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales 2020-2031
1.4.3 Global Sustained Release Ocular Drug Delivery Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sustained Release Ocular Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.8.1 Global Sustained Release Ocular Drug Delivery Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue
2.8.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sustained Release Ocular Drug Delivery Systems Market Scenario by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2020-2031)
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2020-2031)
4.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2020-2031)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2020-2031)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 pSivida
6.1.1 pSivida Company Information
6.1.2 pSivida Description and Business Overview
6.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.1.5 pSivida Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Icon Bioscience
6.3.1 Icon Bioscience Company Information
6.3.2 Icon Bioscience Description and Business Overview
6.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.3.5 Icon Bioscience Recent Developments/Updates
6.4 Ocular Therapeutix
6.4.1 Ocular Therapeutix Company Information
6.4.2 Ocular Therapeutix Description and Business Overview
6.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.4.5 Ocular Therapeutix Recent Developments/Updates
6.5 Neurotech Pharmaceuticals
6.5.1 Neurotech Pharmaceuticals Company Information
6.5.2 Neurotech Pharmaceuticals Description and Business Overview
6.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.5.5 Neurotech Pharmaceuticals Recent Developments/Updates
6.6 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Company Information
6.6.2 Santen Pharmaceutical Description and Business Overview
6.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.6.5 Santen Pharmaceutical Recent Developments/Updates
6.7 Aciont Inc.
6.7.1 Aciont Inc. Company Information
6.7.2 Aciont Inc. Description and Business Overview
6.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.7.5 Aciont Inc. Recent Developments/Updates
6.8 Envisia Therapeutics
6.8.1 Envisia Therapeutics Company Information
6.8.2 Envisia Therapeutics Description and Business Overview
6.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.8.5 Envisia Therapeutics Recent Developments/Updates
6.9 GrayBug
6.9.1 GrayBug Company Information
6.9.2 GrayBug Description and Business Overview
6.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.9.5 GrayBug Recent Developments/Updates
6.10 Innocore Pharmaceuticals
6.10.1 Innocore Pharmaceuticals Company Information
6.10.2 Innocore Pharmaceuticals Description and Business Overview
6.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.10.5 Innocore Pharmaceuticals Recent Developments/Updates
6.11 OHR Pharmaceuticals
6.11.1 OHR Pharmaceuticals Company Information
6.11.2 OHR Pharmaceuticals Description and Business Overview
6.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.11.5 OHR Pharmaceuticals Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Company Information
6.12.2 PolyActiva Description and Business Overview
6.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 TheraKine
6.13.1 TheraKine Company Information
6.13.2 TheraKine Description and Business Overview
6.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.13.5 TheraKine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sustained Release Ocular Drug Delivery Systems Industry Chain Analysis
7.2 Sustained Release Ocular Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sustained Release Ocular Drug Delivery Systems Production Mode & Process Analysis
7.4 Sustained Release Ocular Drug Delivery Systems Sales and Marketing
7.4.1 Sustained Release Ocular Drug Delivery Systems Sales Channels
7.4.2 Sustained Release Ocular Drug Delivery Systems Distributors
7.5 Sustained Release Ocular Drug Delivery Systems Customer Analysis
8 Sustained Release Ocular Drug Delivery Systems Market Dynamics
8.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
8.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
8.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
8.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
pSivida
Allergan plc
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
List of Tables
 Table 1. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sustained Release Ocular Drug Delivery Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sustained Release Ocular Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sustained Release Ocular Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2026-2031)
 Table 70. pSivida Company Information
 Table 71. pSivida Description and Business Overview
 Table 72. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. pSivida Sustained Release Ocular Drug Delivery Systems Product
 Table 74. pSivida Recent Developments/Updates
 Table 75. Allergan Company Information
 Table 76. Allergan Description and Business Overview
 Table 77. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Allergan Sustained Release Ocular Drug Delivery Systems Product
 Table 79. Allergan Recent Developments/Updates
 Table 80. Icon Bioscience Company Information
 Table 81. Icon Bioscience Description and Business Overview
 Table 82. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
 Table 84. Icon Bioscience Recent Developments/Updates
 Table 85. Ocular Therapeutix Company Information
 Table 86. Ocular Therapeutix Description and Business Overview
 Table 87. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
 Table 89. Ocular Therapeutix Recent Developments/Updates
 Table 90. Neurotech Pharmaceuticals Company Information
 Table 91. Neurotech Pharmaceuticals Description and Business Overview
 Table 92. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
 Table 94. Neurotech Pharmaceuticals Recent Developments/Updates
 Table 95. Santen Pharmaceutical Company Information
 Table 96. Santen Pharmaceutical Description and Business Overview
 Table 97. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
 Table 99. Santen Pharmaceutical Recent Developments/Updates
 Table 100. Aciont Inc. Company Information
 Table 101. Aciont Inc. Description and Business Overview
 Table 102. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
 Table 104. Aciont Inc. Recent Developments/Updates
 Table 105. Envisia Therapeutics Company Information
 Table 106. Envisia Therapeutics Description and Business Overview
 Table 107. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
 Table 109. Envisia Therapeutics Recent Developments/Updates
 Table 110. GrayBug Company Information
 Table 111. GrayBug Description and Business Overview
 Table 112. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. GrayBug Sustained Release Ocular Drug Delivery Systems Product
 Table 114. GrayBug Recent Developments/Updates
 Table 115. Innocore Pharmaceuticals Company Information
 Table 116. Innocore Pharmaceuticals Description and Business Overview
 Table 117. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
 Table 119. Innocore Pharmaceuticals Recent Developments/Updates
 Table 120. OHR Pharmaceuticals Company Information
 Table 121. OHR Pharmaceuticals Description and Business Overview
 Table 122. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
 Table 124. OHR Pharmaceuticals Recent Developments/Updates
 Table 125. PolyActiva Company Information
 Table 126. PolyActiva Description and Business Overview
 Table 127. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
 Table 129. PolyActiva Recent Developments/Updates
 Table 130. TheraKine Company Information
 Table 131. TheraKine Description and Business Overview
 Table 132. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. TheraKine Sustained Release Ocular Drug Delivery Systems Product
 Table 134. TheraKine Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Sustained Release Ocular Drug Delivery Systems Distributors List
 Table 138. Sustained Release Ocular Drug Delivery Systems Customers List
 Table 139. Sustained Release Ocular Drug Delivery Systems Market Trends
 Table 140. Sustained Release Ocular Drug Delivery Systems Market Drivers
 Table 141. Sustained Release Ocular Drug Delivery Systems Market Challenges
 Table 142. Sustained Release Ocular Drug Delivery Systems Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sustained Release Ocular Drug Delivery Systems
 Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type: 2024 & 2031
 Figure 4. Liposome Product Picture
 Figure 5. Microcapsules/Nanocapsules Product Picture
 Figure 6. Microspheres/Nanosptheres Product Picture
 Figure 7. Implants Product Picture
 Figure 8. Global Sustained Release Ocular Drug Delivery Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application: 2024 & 2031
 Figure 10. Cataract
 Figure 11. Glaucoma
 Figure 12. Corneal Transplantation
 Figure 13. Others
 Figure 14. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Sustained Release Ocular Drug Delivery Systems Sales (2020-2031) & (K Pcs)
 Figure 17. Global Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Sustained Release Ocular Drug Delivery Systems Report Years Considered
 Figure 19. Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers in 2024
 Figure 20. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Sustained Release Ocular Drug Delivery Systems Players: Market Share by Revenue in Sustained Release Ocular Drug Delivery Systems in 2024
 Figure 22. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 25. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 29. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2020-2031)
 Figure 37. China Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2020-2031)
 Figure 59. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2020-2031)
 Figure 62. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Sustained Release Ocular Drug Delivery Systems Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Ocular Drug Delivery Devices Market Research Report 2025
Global Ocular Drug Delivery Market Research Report 2025
Ophthalmic Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drug Market Insights Forecast to 2030
Pharma Sustained Release Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Inflammation Treatment Market Research Report 2025
Global Pharma Ophthalmic Market Research Report 2025
Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorder Treatment Market Research Report 2024
Eye Ointments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Eye Drops and Eye Ointments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global Dental Drug Delivery System Market Insights Forecast to 2030
Global Glaucoma Medications Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions